These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 33301778)
21. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Hundt S; Haug U; Brenner H Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905 [TBL] [Abstract][Full Text] [Related]
22. Immunochemical fecal occult blood test is not suitable for diagnosis of hemorrhoids. Nakama H; Kamijo N; Fujimori K; Horiuchi A; Abdul Fattah S; Zhang B Am J Med; 1997 Jun; 102(6):551-4. PubMed ID: 9217670 [TBL] [Abstract][Full Text] [Related]
23. [Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening]. García Sánchez J Rev Clin Esp; 2012 Jul; 212(7):407. PubMed ID: 22937539 [No Abstract] [Full Text] [Related]
25. Colorectal Cancer Screening by Colonoscopy, CT-Colonography, or Fecal Immunochemical Test. Kuipers EJ; Spaander MC J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26719226 [No Abstract] [Full Text] [Related]
26. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797 [TBL] [Abstract][Full Text] [Related]
27. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial. You JJ; Liu Y; Kirby J; Vora P; Moayyedi P Trials; 2015 Jul; 16():296. PubMed ID: 26156248 [TBL] [Abstract][Full Text] [Related]
28. A Clinician's Guide to Fecal Occult Blood Testing for Colorectal Cancer. Bechtold ML; Ashraf I; Nguyen DL South Med J; 2016 Apr; 109(4):248-55. PubMed ID: 27043809 [TBL] [Abstract][Full Text] [Related]
29. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Worthley DL; Smith A; Bampton PA; Cole SR; Young GP Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514 [TBL] [Abstract][Full Text] [Related]
30. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients. Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570 [TBL] [Abstract][Full Text] [Related]
31. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy. Kim NH; Jung YS; Lim JW; Park JH; Park DI; Sohn CI Gastrointest Endosc; 2019 May; 89(5):1037-1043. PubMed ID: 30684602 [TBL] [Abstract][Full Text] [Related]
32. The COVID-19 pandemic and colorectal cancer prevention: God tempers the wind to the shorn lamb. Pellisé M Endoscopy; 2020 Oct; 52(10):877-878. PubMed ID: 32967017 [No Abstract] [Full Text] [Related]
33. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183 [TBL] [Abstract][Full Text] [Related]
34. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942 [TBL] [Abstract][Full Text] [Related]
35. Impact of the COVID-19 pandemic during Spain's state of emergency on the diagnosis of colorectal cancer. Suárez J; Mata E; Guerra A; Jiménez G; Montes M; Arias F; Ciga MA; Ursúa E; Ederra M; Arín B; Laiglesia M; Sanz A; Vera R J Surg Oncol; 2021 Jan; 123(1):32-36. PubMed ID: 33078425 [TBL] [Abstract][Full Text] [Related]
36. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme. Rodger J; Steele RJ J Med Screen; 2008; 15(2):105-7. PubMed ID: 18573779 [TBL] [Abstract][Full Text] [Related]
37. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results. Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. O'Leary BA; Olynyk JK; Neville AM; Platell CF J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241 [TBL] [Abstract][Full Text] [Related]
39. Colorectal Cancer Screening: Is Colonoscopy the Best Option? Liang PS; Dominitz JA Med Clin North Am; 2019 Jan; 103(1):111-123. PubMed ID: 30466668 [TBL] [Abstract][Full Text] [Related]
40. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer? Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]